×
In

Clear Eyes eye drops recalled nationwide over contamination risk, FDA says

A New York-based consumer healthcare company is recalling nearly 40,000 bottles of eye drops over concerns about the product’s sterility. 

Prestige Consumer Healthcare initiated the recall on July 29 due to “lack of assurance of sterility,” according to a U.S. Food and Drug Administration notice.

“The recall is due to potential contamination,” the notice says.

The recall affects 15mL bottles of Clear Eyes’ Maximum Itchy Eye Relief, which mitigates itchiness, redness and other eye irritations, according to the product description. The eye drops were distributed nationwide.

The FDA categorized the recall as Class II, which means a product could cause “temporary or medically reversible adverse health consequences,” according to the agency’s definition.

Prestige Consumer Healthcare did not immediately respond to a request for comment.

Recall info

  • Recall number: D-0766-2026
  • Lot code: 2552A
  • Expiration date: September 30, 2027 


Original source: https://www.cbsnews.com/world/

Leave a Reply

Your email address will not be published. Required fields are marked *

Author

seoexperts1994@gmail.com

Related Posts

In

Boat capsizes in northwestern Nigeria, leaving dozens of people dead

Boat capsizes in northwestern Nigeria, leaving dozens of people deadThe boat was carrying more than 80 people, most of whom were heading...

Read out all
In

Express train hits and kills 4 workers at a railway station in Japan

Express train hits and kills 4 workers at a railway station in JapanThe accident occurred at Shin-Kanuma Station, north of Tokyo, on...

Read out all
In

USS Lincoln heads home after extended deployment to the Middle East

USS Lincoln heads home after extended deployment to the Middle EastService members and their families had complained about deteriorating morale on the...

Read out all
In

Dan Green wins crowded GOP primary in Florida’s 9th District

Politics Dan Green wins crowded GOP primary in Florida's 9th District By Caitlin Yilek Politics Reporter Caitlin Yilek is a politics reporter...

Read out all
In

Moderna stock more than doubles after melanoma vaccine trial shows “landmark moment”

MoneyWatch Moderna stock more than doubles after melanoma vaccine trial shows "landmark moment" By Megan Cerullo Reporter, MoneyWatch Megan Cerullo is a...

Read out all
In

FTC says “personalized pricing” based on consumer data could violate the law

MoneyWatch FTC says "personalized pricing" based on consumer data could violate the law By Megan Cerullo Reporter, MoneyWatch Megan Cerullo is a...

Read out all